| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―06 |
1696-P: Effect of Semaglutide on COVID-19-Related Complications and All-Cause Death: Pooled Analyses of the SELECT, FLOW, and SOUL Trials |
BENJAMIN SCIRICA, JOHN B. BUSE, ANDREI MIRCEA CATARIG, OLE K. JEPPESEN, ABRAHAM M. LINCOFF, DARREN MCGUIRE, VLADO PERKOVIC, RICHARD PRATLEY, SIGNE STENSEN, MINH CHAU TRAN, DONNA RYAN |
| 2 |
[GO] |
2026―Jun―06 |
2349-P: In-Hospital Mortality among Patients with Diabetes During and After the COVID-19 Pandemic: A Population-Based Study |
MINGJIA LI, MIAOMIAO ZHAO, QI LI, JIN-KUI YANG |
| 3 |
[GO] |
2026―Jun―06 |
2299-P: Evolving Burden of Chronic Kidney Disease and In-Hospital Mortality among Type 2 Diabetes Mellitus Admissions in California Before and After the COVID-19 Pandemic (2016-2022) |
LEE SASAKI, LOGAN CANTRELL, KATHERINE KIM, MINH TRINH, ANURA W.G. RATNASIRI |
| 4 |
[GO] |
2026―Jun―06 |
1163-OR: Paxlovid Use for SARS-CoV-2 Infection and Two-Year Risk of Diabetes: The COVID-19 and Diabetes Assessment (CODA) Study |
BAHAREH RASOULI, SHERYL RIFAS-SHIMAN, JESSICA G. YOUNG, THOMAS EGGERMAN, BENJAMIN FRENCH, MARIE-FRANCE HIVERT, SEAN MCGRATH, ALVIN C. POWERS, JENNIFER LYONS, RUSSELL L. ROTHMAN, JONATHAN S. SCHILDCROUT, JASON P. BLOCK |
| 5 |
[GO] |
2026―Jun―05 |
1420-P: Temporal Trends and Sociodemographic Disparities in Acute Myocardial Infarction Outcomes among Hospitalized Patients with Diabetes Mellitus: Impact of the COVID-19 Pandemic in California, 2016-2022 |
BUDDHIKA RATNASIRI, ANURA W.G. RATNASIRI, LEONARD E. RANASINGHE, RADHIKA N. BUKKAPATNAM, JAVIER LOPEZ |
| 6 |
[GO] |
2026―Jun―05 |
2049-P: Longitudinal Changes in Diabetes Care Delivery Before and During the COVID-19 Pandemic |
HENG YEH, ELSA ACEVEDO MARTINEZ, KAMAHL HARRISINGH, QUAN NGUYEN, SUPRIYA SIGDEL, JESSICA GOLDBERG, ANITA SIKHA, CHRISTOPHER CHANG |
| 7 |
[GO] |
2026―Jun―05 |
2342-P: Natural History of New Diabetes after COVID-19 Infection: The COVID-19 and Diabetes Assessment (CODA) Study |
JENNIFER G. LYONS, SHERYL RIFAS-SHIMAN, JESSICA G. YOUNG, THOMAS EGGERMAN, BENJAMIN FRENCH, MARIE-FRANCE HIVERT, SEAN MCGRATH, ALVIN C. POWERS, BAHAREH RASOULI, RUSSELL L. ROTHMAN, JONATHAN S. SCHILDCROUT, JASON P. BLOCK |
| 8 |
[GO] |
2025―Jun―13 |
2052-LB: Holding the Line-Hemoglobin A1c and Rates of Laboratory Testing Did Not Change during the Pandemic at a Student-Run Free Clinic |
JIMMY YU, EDWARD C. CHAO, NATALIE RODRIGUEZ, MICHELLE JOHNSON |
| 9 |
[GO] |
2025―Jun―13 |
1351-P: New-Onset Hyperglycemia in COVID-19-An Indian Perspective on Clinical Outcomes and Management |
SHIVEN BHANDARI, SUDHIR BHANDARI, SHASHANK JOSHI, BANSHI D. SABOO, GOVIND RANKAWAT, LALIT WADHAWAN |
| 10 |
[GO] |
2025―Jun―13 |
2099-LB: Relationship between COVID-19 Variants and Diabetes Incidence |
SHERYL L. RIFAS-SHIMAN, JESSICA YOUNG, SEAN MCGRATH, JONATHAN S. SCHILDCROUT, NISHADI DE ABREW RAJAPAKSE, MARIE-FRANCE HIVERT, JENNIFER LYONS, ALVIN C. POWERS, BAHAREH RASOULI, RUSSELL L. ROTHMAN, JASON P. BLOCK |
| 11 |
[GO] |
2025―Jun―13 |
1447-P: Impact of the COVID-19 Pandemic on the Diabetes Prevention Program Outcomes Study (DPPOS) |
ASHLEY H. TJADEN, KARLA A. TEMPLE, SHARON EDELSTEIN, WILLIAM C. KNOWLER, VALLABH SHAH, SHIHCHEN KUO, PANDORA WANDER, MARIA ROSARIO G. ARANETA, JAMES M. NOBLE, DANA DABELEA, ROBERT L. DUBIN, JILL P. CRANDALL, DPP RESEARCH GROUP |
| 12 |
[GO] |
2025―Jun―13 |
1341-P: The Impact of the COVID-19 Pandemic on Diabetes Detection |
CHENGCHENG HU, MOHAMMED K. ALI, RODRIGO M. CARRILLO-LARCO, JITHIN SAM VARGHESE, JESSICA L. HARDING |
| 13 |
[GO] |
2025―Jun―13 |
1354-P: The Impact of the COVID-19 Pandemic on Diabetes Control |
JESSICA L. HARDING, CHENGCHENG HU, JITHIN SAM VARGHESE, RODRIGO M. CARRILLO-LARCO, MOHAMMED K. ALI |
| 14 |
[GO] |
2025―Jun―13 |
2108-LB: Cluster Analysis Reveals Increased Proportion of Patients with Severe Diabetes Subtypes following the COVID-19 Pandemic |
BRIAN LU, PENG LI, ANDREW CROUSE, TIFFANY GRIMES, AVA N. SMITH, MATTHEW MIGHT, FERNANDO OVALLE, ANATH SHALEV |
| 15 |
[GO] |
2025―Jun―13 |
1159-P: Incidence and Remission Rates of Youth-Onset Type 2 Diabetes (Y-T2D) after Virtual Learning (VL) during the COVID-19 Pandemic |
JODY GRUNDMAN, RACHEL L. LONGENDYKE, DORIS E. ESTRADA, STEPHANIE T. CHUNG |
| 16 |
[GO] |
2025―Jun―13 |
67-OR: Longitudinal Trends in Diabetic Foot Ulcers and Lower Extremity Amputations before and after the COVID-19 Pandemic |
IVAN Y. LUU, ALEXANDER T. HONG, LAURA SHIN, CHIA-DING SHIH, SUKGU M. HAN, DAVID G. ARMSTRONG, TZE-WOEI TAN |
| 17 |
[GO] |
2025―Jun―13 |
474-P: Progression of Diabetic Retinopathy in Wales during the COVID-19 Pandemic |
REBECCA L. THOMAS, WAI YEE CHEUNG, JAMES RAFFERTY, LUKE PRATT, JOCELYN CHERRY, RHIANON REYNOLDS, GWYN WILLIAMS, STEPHEN C. BAIN, DAVID R. OWENS |
| 18 |
[GO] |
2025―Jun―13 |
1299-P: Trends in Diabetes-Related Heart Failure Hospitalizations and Mortality in California before and after the COVID-19 Pandemic |
KARINA GARZONA, CHANEL MANZANO, TROY SMITH-BOVA, ANURA W.G. RATNASIRI |
| 19 |
[GO] |
2025―Jun―13 |
1337-P: Impact of COVID-19 on Diabetic Eye Screening-A Retrospective Study Exploring Outcomes and Disparities |
KASHIR A. RAZA, FARHAN ZAIDI, DAVID R. OWENS |
| 20 |
[GO] |
2025―Jun―13 |
12-PUB: Improved Glycemic Control among Individuals with Long-Standing Diabetes during COVID-19 Lockdown-An Observational Study |
DARSHANKUMAR RAVAL, VAISHNAVI M. RATHOD, RASHMI PATIL, KOMAL RANA, AMALKUMAR BHATTACHARYA |
| 21 |
[GO] |
2025―Jun―13 |
1456-P: Clinical Course of Incident Diabetes in American Indian and Alaska Native People following COVID-19 Illness |
JAMES KECK, SARA BRESSLER, MARY E. LACY |
| 22 |
[GO] |
2025―Jan―28 |
Identification of CD209 as an Intervention Target for Type 2 Diabetes after COVID-19 Infection: Insights from Proteome-wide Mendelian Randomization |
Jiaying Zhang, Feng Jiao, Zhenqian Wang, Chenfeng Zou, Xiangjun Du, Dewei Ye, Guozhi Jiang |
| 23 |
[GO] |
2024―Dec―23 |
SARS-CoV-2 Spike S1 subunit triggers pericyte and microvascular dysfunction in human pancreatic islets |
Catarina Andrade Barboza, Luciana Mateus Gonçalves, Elizabeth Pereira, Roxana Diaz Cruz, Ruy Louzada, Maria Boulina, Joana Almaça |
| 24 |
[GO] |
2024―Jul―19 |
1388-P: Risk of Diabetes among Children and Young Adults after COVID-19 Infection-The DiCAYA Study |
SARAH CONDERINO, H. LESTER KIRCHNER, LORNA THORPE, JASMIN DIVERS, ANNEMARIE G. HIRSCH, CARA M. NORDBERG, BRIAN S. SCHWARTZ, BO CAI, CAROLINE RUDISILL, JIHAD S. OBEID, ANGELA D. LIESE, BRIAN E. DIXON, DANA DABELEA, ANNA BELLATORRE, HUI SHAO, JIANG BIAN, YI GUO, KRISTI REYNOLDS, MATTHEW T. MEFFORD, MANMOHAN K. KAMBOJ, ENEIDA A. MENDONCA, KATIE ALLEN, SHAWNA BURGETT, EVA LUSTIGOVA, SARAH BOST, MITCH MALTENFORT, LEVON H. UTIDJIAN, MATT M. ZHOU, TESSA L. CRUME, ANDREA TITUS |
| 25 |
[GO] |
2024―Jun―21 |
2095-LB: Impact of SARS-CoV-2 Spike Proteins on the Islet Microvascular Function |
CATARINA BARBOZA, LUCIANA MATEUS GONCALVES, JOANA ALMACA |
| 26 |
[GO] |
2024―Jun―14 |
1519-P: Endothelial Injury Predicts Carbohydrate Metabolism Trajectories after COVID-19 |
JANE E.B. REUSCH, DAVID ALBERS, YANRAN WANG, JENNIFER BRIGGS, RICHARD MAICKI, J.N. STROH, AANCHAL GUPTA, ANN GARCIA, VATSALA SINGH, TERRA D. HILLER, ARTHUR SHERMAN, NEDA RASOULI, IVOR S. DOUGLAS |
| 27 |
[GO] |
2024―Jun―14 |
422-P: Ferritin and COVID-19 among Dialysis Patients with Diabetes |
TALIA QUANDELACY, MING HU, YUEDONG WANG, PETER KOTANKO, REBECCA B. CONWAY |
| 28 |
[GO] |
2024―Jun―14 |
1422-P: Understanding COVID-19 Impacts among Underserved Adults with Diabetes Using the Social-Ecological Model |
JENNIFER MAIZEL, RITHWIK ATTANTI, KEERTHI PRASANNA CHENNURI, RILEY SMITH, STEPHANIE L. FILIPP, MELANIE HECHAVARRIA, MICHAEL J. HALLER, SARAH WESTEN, BRITTNEY DIXON, DAVID M. MAAHS, RAYHAN LAL, ANANTA ADDALA, ASHBY F. WALKER |
| 29 |
[GO] |
2024―Jun―14 |
1585-P: Changes in Metabolic Health following COVID-19 in Persons with Type 2 Diabetes Mellitus |
IRYNA YURCHENKO, YULIYA KUPRIYANOVA, PAVEL BOBROV, VOLKER BURKART, ROBERT WAGNER, VERA SCHRAUWEN-HINDERLING, MICHAEL RODEN |
| 30 |
[GO] |
2024―Jun―14 |
1396-P: Association between COVID-19 Infection and Incident Diabetes in Two Distinct Cohorts-A Nationwide Commercial Claims Database and a Regional Academic Medical Center |
MARY E. LACY, AARON P. SMITH, LINDSEY R. HAMMERSLAG, KORY HEIER, ALICIA B. FIELDS, JEFFERY TALBERT, JOHN FOWLKES, SIMON J. FISHER, PHILIP A. KERN |
| 31 |
[GO] |
2024―Jun―14 |
421-P: Ferritin and COVID-19 Infection and Outcomes in American Indian and Alaska Native Dialysis Patients with Diabetes |
MING HU, TALIA QUANDELACY, YUEDONG WANG, PETER KOTANKO, REBECCA B. CONWAY |
| 32 |
[GO] |
2024―Jun―14 |
1428-P: Impact of Socioeconomic Inequalities on COVID-19 Mortality of People Living with Diabetes during the 2020 Epidemic Waves in France |
MARIE GUION, SARAH GORIA, SANDRINE FOSSE-EDORH, EMMANUEL COSSON |
| 33 |
[GO] |
2024―Jun―14 |
1065-P: Comparative Effectiveness of the Bivalent COVID-19 mRNA Vaccines mRNA1273-222 and BNT162b2 in Adults with Diabetes in the U.S. |
HAGIT KOPEL, VAN HUNG NGUYEN, ALINA BOGDANOV, ISABELLE WINER, CATHERINE BOILEAU, THIERRY DUCRUET, NI ZENG, MARY BAUSCH-JURKEN, DAINA B. ESPOSITO, EKKEHARD BECK, MAC BONAFEDE, JAMES A. MANSI |
| 34 |
[GO] |
2024―Jun―14 |
1364-P: Racial and Ethnic Disparities in COVID-19 Outcomes among Dialysis Patients with Diabetes |
REBECCA B. CONWAY, TALIA QUANDELACY, MING HU, YUEDONG WANG, PETER KOTANKO |
| 35 |
[GO] |
2024―Jun―14 |
1431-P: Dramatic Reduction in Prevalence of Increase of Insulin Resistance in 14- to 15-Year-Old Students after the COVID-19 Pandemic |
TAKAYUKI OHNO, MIZUKI ISHIGURO, YUKA SUGANUMA, RIMEI NISHIMURA |
| 36 |
[GO] |
2024―Jun―14 |
1158-P: Racial Disparities in Youth with Diabetes and the COVID-19 Pandemic |
UMA L. MUZUMDAR, CHRISTINE MARCH, NKEIRUKA MKPARU, INGRID LIBMAN |
| 37 |
[GO] |
2024―Jun―14 |
728-P: Experience with Teplizumab in the PROTECT Type 1 Diabetes (T1D) Study during the COVID-19 Pandemic |
STEPHEN E. GITELMAN, KEVAN C. HEROLD, KIMBER M. SIMMONS, ZDENEK SUMNIK, LAURA KNECHT, ELISABETH NIEMOELLER, WEI TIAN, GAIL M. COMER, DIANA E. MILLER, ELEANOR L. RAMOS |
| 38 |
[GO] |
2024―Jun―14 |
1354-P: Diabetes-Related Acute Complications during the COVID-19 Pandemic among Medicare Fee-for-Service Beneficiaries |
XILIN ZHOU, LINDA J. ANDES, DEBORAH B. ROLKA |
| 39 |
[GO] |
2024―Jun―14 |
1818-LB: The Influence of COVID-19 Pandemic on Diabetic Foot Amputations in a Western Amazon Hospital |
HERCULES M. CARMO |
| 40 |
[GO] |
2024―Jun―14 |
1974-LB: Impact of Maternal Hyperglycemic and Hypertensive Disorders on Adverse Pregnancy Outcomes across the COVID-19 Pandemic-A Comprehensive Analysis in an Underserved Population |
LIXIA ZHANG, YUN SHEN, GANG HU |
| 41 |
[GO] |
2024―Jun―14 |
1384-P: COVID-19 Vaccination Uptake among 3,779,733 Adults With and Without Diabetes |
SONIA BUTALIA, BAIJU R. SHAH, RONALD J. SIGAL, JAMIE L. BENHAM, BRANDY WICKLOW, CATHERINE H. YU, KABERI DASGUPTA, SHAZHAN AMED, CORA CONSTANTINESCU, MANH LUAN CHU, PADMA KAUL |
| 42 |
[GO] |
2024―Jun―14 |
1855-LB: Metformin Mitigates Insulin Signaling Variations Induced by COVID-19 Vaccine Boosters in Type 2 Diabetes |
MIN ZHUANG, LIXIANG ZHAI, ZHAOXIANG BIAN, CHENGYUAN LIN, KI WONG HOI |
| 43 |
[GO] |
2024―Jun―14 |
679-P: "COVID Is Not My Concern; Diabetes Is"-Understanding COVID-19 Vaccine Hesitancy among Underserved Adults with Diabetes Using the 3 Cs Model |
JENNIFER MAIZEL, TAIS A. BAUTISTA, ISA N. PRUDE, STEPHANIE L. FILIPP, MELANIE HECHAVARRIA, MICHAEL J. HALLER, SARAH WESTEN, BRITTNEY DIXON, DAVID M. MAAHS, RAYHAN LAL, ANANTA ADDALA, ASHBY F. WALKER |
| 44 |
[GO] |
2024―Jun―14 |
37-OR: Effectiveness of Continuous Glucose Monitoring on Short-Term In-Hospital Mortality among Frail Critically Ill Patients with COVID-19-An Exploratory, Prospective, Randomized, Open-Label, Parallel, Single-Center, Randomized Clinical Trial |
WEI WANG, YUN SHEN |
| 45 |
[GO] |
2024―Jun―14 |
1990-LB: Associations of SARS-CoV-2 Infection with Incident Diabetes among U.S. Veterans in a Longitudinal Observational Cohort |
LIUYE HUANG, JONATHAN D. SUGIMOTO, JAVEED A. SHAH, JENNIFER LEE, PANDORA WANDER |
| 46 |
[GO] |
2024―Jun―14 |
1306-P: Type 2 Diabetes Screening in the 12 Months following Acute SARS-CoV-2 Infection-A Real-World Cohort Analysis |
RUWANTHI N. EKANAYAKE, ROSETTE CHAKKALAKAL, MOHAMMED K. ALI, JITHIN SAM VARGHESE |
| 47 |
[GO] |
2024―Jun―14 |
1390-P: Access to Telehealth and Changes in Diabetes Care Patterns during the Pandemic |
SOFIA A. OVIEDO, JENNIFER C. GANDER, BENNETT MCDONALD, MOHAMMED K. ALI, JESSICA L. HARDING |
| 48 |
[GO] |
2023―Jul―20 |
Response to Comment on Baranova et al. Causal Associations Between Basal Metabolic Rate and COVID-19. Diabetes 2023;72:149-154 |
Fuquan Zhang, Ancha Baranova |
| 49 |
[GO] |
2023―Jul―20 |
Comment on Baranova et al. Causal Associations Between Basal Metabolic Rate and COVID-19. Diabetes 2023;72:149-154 |
David E. Kloecker, Søren Brage, Nicholas J. Wareham |
| 50 |
[GO] |
2023―Jun―23 |
1842-PUB: Ischemic Stroke in Patients with Diabetes Mellitus during COVID-19 Pandemic in South Korea, Using National Emergency Department Information System |
MIN JEONG PARK, SOO YEON JANG, KYUNG MOOK CHOI, SEI HYUN BAIK, HYE JIN YOO |
| 51 |
[GO] |
2023―Jun―23 |
1841-PUB: Diabetes as a Risk Factor of Death in Hospitalized COVID-19 Patients-An Analysis of a National Hospitalization Database from Poland, 2020 |
MICHAL KANIA, BEATA KON, KONRAD M. KAMINSKI, JERZY HOHENDORFF, TOMASZ KLUPA, PRZEMYSLAW W. WITEK, MACIEJ MALECKI |
| 52 |
[GO] |
2023―Jun―23 |
1838-PUB: Impact of COVID-19 on New-Onset Pediatric Diabetes Diagnoses |
KATHERINE SIMMS, SARAH GREEN, MAMTA SHAH, MEDINA SAREINI, CINDY CHIN |
| 53 |
[GO] |
2023―Jun―23 |
1812-PUB: Safety and Effectiveness of Empagliflozin/Linagliptin FDC in Uncontrolled T2DM Patients with COVID-19 Infection |
ASOKTARU SENGUPTA |
| 54 |
[GO] |
2023―Jun―23 |
1792-PUB: Predictors of Weight Loss Variability in the COVID-19 Disrupted ACT1ON Diet Pilot in Young Adults with T1D |
DARIA IGUDESMAN, ANANTA ADDALA, JAMIE CRANDELL, FRANKLIN R. MUNTIS, DESSI P. ZAHARIEVA, JOAN THOMAS, KAREN CORBIN, ANNA CASU, M. SUE KIRKMAN, MICHAEL R. KOSOROK, RICHARD E. PRATLEY, DAVID M. MAAHS, ELIZABETH J. MAYER-DAVIS |
| 55 |
[GO] |
2023―Jun―23 |
1798-PUB: Clinical Factors Associated with Positive Depression Screen in Youth with Type 1 Diabetes Before and During the COVID 19 Pandemic |
SWETHA SRIRAM, CHRISTINE MARCH, LINDSAY M. LEIKAM, JUSTIN SCHREIBER, RADHIKA MUZUMDAR, INGRID LIBMAN |
| 56 |
[GO] |
2023―Jun―20 |
994-P: Excess Medical Expenditures and Out-of-Pocket Costs Associated with COVID-19 among Medicare Beneficiaries with Diabetes |
YU WANG, PING ZHANG, XILIN ZHOU, GIUSEPPINA IMPERATORE |
| 57 |
[GO] |
2023―Jun―20 |
145-LB: Consistent Care of Teens and Young Adults with Diabetes during the COVID-19 Pandemic |
DANIEL S. HSIA, ROBBIE A. BEYL, RENEE RUMSEY |
| 58 |
[GO] |
2023―Jun―20 |
700-P: Outcomes of a Diabetes Support Coach Intervention Implemented during the COVID-19 Pandemic |
JENNIFER MAIZEL, MICHAEL J. HALLER, DAVID M. MAAHS, ANANTA ADDALA, RAYHAN LAL, LAUREN FIGG, MELANIE HECHAVARRIA, KEILECIA G. MALDEN, ELENI SHEEHAN, SARAH C. WESTEN, KOREY K. HOOD, JESSIE J. WONG, BRITTNEY DIXON, STEPHANIE L. FILIPP, MATTHEW J. GURKA, ASHBY F. WALKER |
| 59 |
[GO] |
2023―Jun―20 |
1152-P: COVID-19 Vaccination Status and Attitudes of Adolescents with T1D and Their Caregivers |
NKEMJIKA OKONKWO, SARAH S. JASER |
| 60 |
[GO] |
2023―Jun―20 |
1410-P: Impacts of COVID-19 on Underserved Communities with Diabetes |
JENNIFER MAIZEL, MICHAEL J. HALLER, DAVID M. MAAHS, ANANTA ADDALA, RAYHAN LAL, STEPHANIE L. FILIPP, MATTHEW J. GURKA, SARAH C. WESTEN, BRITTNEY DIXON, LAUREN FIGG, MELANIE HECHAVARRIA, KEILECIA G. MALDEN, ASHBY F. WALKER |
| 61 |
[GO] |
2023―Jun―20 |
1275-P: Incident Diabetes Before and During the COVID-19 Pandemic among Youth in Kaiser Permanente Southern California |
MATTHEW T. MEFFORD, RONG WEI, EVA LUSTIGOVA, JOHN P. MARTIN, KRISTI REYNOLDS |
| 62 |
[GO] |
2023―Jun―20 |
993-P: Changes in Medical Expenditures and Out-of-Pocket Costs in Medicare Beneficiaries with Diabetes during the COVID-19 Pandemic |
YU WANG, PING ZHANG, XILIN ZHOU, DEBORAH B. ROLKA, GIUSEPPINA IMPERATORE |
| 63 |
[GO] |
2023―Jun―20 |
1232-P: Risk of Cardiovascular Diseases >30 Days after COVID-19 Diagnosis among U.S. Adults With and Without Diabetes |
ALAIN KOYAMA, GIUSEPPINA IMPERATORE, DEBORAH B. ROLKA, ELIZABETH A. LUNDEEN, RACHEL RUTKOWSKI, SANDRA JACKSON, SIRAN HE, ELENA V. KUKLINA, SOYOUN PARK, MEDA E. PAVKOV |
| 64 |
[GO] |
2023―Jun―20 |
277-LB: Weight Cycling Is Associated with ICU Admission and Mechanical Ventilation in Adults with Diabetes Hospitalized with COVID-19 |
YU MI KANG, DONALD C. SIMONSON, AKSHATA S. CHAUGULE, RAJESH K. GARG, GEETHA GOPALAKRISHNAN, KYRA HOWARD, JASMIN LEBASTCHI, JOANNA MITRI, NADINE E. PALERMO, RUTH S. WEINSTOCK, MARIE E. MCDONNELL |
| 65 |
[GO] |
2023―Jun―20 |
635-P: Health Disparities among People With and Without Diabetes during 24 Months of the COVID-19 Pandemic |
BARBARA A. MYERS, RACHEL KLINGENSMITH, FARRAH ANWAR, INES G. GONZALEZ CASANOVA, MARY DE GROOT |
| 66 |
[GO] |
2023―Jun―20 |
1289-P: Predictors of New-Onset Type 2 Diabetes after Infection with COVID-19 in the COVID-OUT Randomized Trial |
JACINDA M. NICKLAS, ESTEBAN J. LEMUS WIRTZ, THOMAS A. MURRAY, DAVID LIEBOVITZ, SARAH FENNO, BLAKE ANDERSON, NANDINI AVULA, NEHA REDDY, CAROLYN BRAMANTE |
| 67 |
[GO] |
2023―Jun―20 |
952-P: The Accuracy and Feasibility of Continuous Glucose Monitoring in COVID-19 Non-Critically Ill Hospitalized Patients-A Pilot Study |
CHOOMPUNUJ SAKJIRAPAPONG, SIRINART SIRINVARAVONG, LUKANA PREECHASUK, NUNTAKORN THONGTANG |
| 68 |
[GO] |
2023―Jun―20 |
1202-P: Comparison of the Clinical Characteristics, Glycemic Control, and Pregnancy Outcomes between Wave I and III of COVID-19 Pandemic in Women with Gestational Diabetes Mellitus-A Reference Center Report |
MAGDALENA WILK, MICHAL KANIA, MACIEJ MALECKI |
| 69 |
[GO] |
2023―Jun―20 |
1420-P: Predictors of Readmission and Mortality in Adults with Diabetes or Stress Hyperglycemia after Initial Hospitalization for COVID-19 |
AKSHATA S. CHAUGULE, KYRA HOWARD, DONALD C. SIMONSON, MARIE E. MCDONNELL, RAJESH K. GARG, GEETHA GOPALAKRISHNAN, JOANNA MITRI, JASMIN LEBASTCHI, NADINE E. PALERMO, GREGORY P. WESTCOTT, RUTH S. WEINSTOCK |
| 70 |
[GO] |
2023―Jun―20 |
487-P: Cardiovascular Autonomic Function in Long COVID-19 Individuals With and Without Diabetes |
JESPER FLEISCHER, SEJAL V.G. GUNARATNAM, YIYUAN HUANG, LYNN ANG, MORTEN CHARLES, AIMEE KATONA, NICOLE BAKER, KARA R. MIZOKAMI-STOUT, YU KUEI LIN, ALEXI VASBINDER, SALIM HAYEK, RODICA BUSUI |
| 71 |
[GO] |
2023―Jun―20 |
1184-P: No Increased Risk of Gestational Diabetes Mellitus (GDM) Diagnosis after COVID-19 Vaccination |
KIMBERLY K. VESCO, ANNA DENOBLE, HEATHER S. LIPKIND, ELYSE KHARBANDA, MALINI B. DESILVA, MATTHEW F. DALEY, DARIOS GETAHUN, OUSSENY ZERBO, ALLISON NALEWAY, LISA JACKSON, JOSHUA WILLIAMS, THOMAS G. BOYCE, CANDACE FULLER, GABRIELA VAZQUEZ BENITEZ |
| 72 |
[GO] |
2023―Jun―20 |
1391-P: National Retrospective Cohort Study of COVID-19 Infection and Incident Diabetes in American-Indian/Alaska-Native People |
JAMES KECK, SARA BRESSLER, MICHAEL BRUCE, UZO CHUKWUMA, MARY E. LACY |
| 73 |
[GO] |
2023―Jun―20 |
1443-P: Population-Based Survey Showing No Increased Incidence of Type 1 Diabetes in Association with COVID-19 Vaccination in China |
CHANG LIU, ZHONG XIN, JIN-KUI YANG |
| 74 |
[GO] |
2023―Jun―20 |
1702-P: Altered Gene Expression Signatures following COVID-19 Infections and/or mRNA Vaccination in Human Adipose Tissue |
SONTJE KRUPKA, MATTHIAS BLÜHER, NORA KLÖTING |
| 75 |
[GO] |
2023―Jun―20 |
546-P: Impact of the COVID-19 Public Health Emergency on Enrollment and Outcomes in the National Diabetes Prevention Program |
ELIZABETH ELY |
| 76 |
[GO] |
2023―Jun―20 |
547-P: Impact of the COVID-19 Public Health Emergency on Delivery of the National Diabetes Prevention Program Lifestyle Change Program |
ELIZABETH ELY |
| 77 |
[GO] |
2023―Jun―20 |
103-LB: Impact of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in COVID-19 Patients with Preexisting Type 2 Diabetes (T2D) and Cardiovascular Disease (CVD) |
CHI NGUYEN, CHRISTOPHER L. CROWE, EFFIE KUTI, BONNIE M.K. DONATO, RACHEL L. DJARAHER, LEO J. SEMAN, NANCY GRAETER, THOMAS P. POWER, VINCENT WILLEY |
| 78 |
[GO] |
2023―Jun―20 |
210-LB: Impact of COVID-19 Pandemic on the Outcomes of Patients with Diabetes in Colombia |
JOSÉ MORENO-MONTOYA, SILVIA BALLESTEROS, JOSÉ DE LA HOZ-VALLE |
| 79 |
[GO] |
2023―Jun―20 |
911-P: Changes in Metrics of Continuous Glucose Monitoring during COVID-19 in Children and Adolescents with Type 1 Diabetes |
HWA YOUNG KIM, SOHYUN SHIN, SE YOUNG KIM, JAEHYUN KIM |
| 80 |
[GO] |
2023―Jun―20 |
998-P: Changes in Health Care Utilization and Costs among Commercially Insured U.S. Adults with Diabetes during the COVID-19 Pandemic |
XILIN ZHOU, ELIZABETH A. LUNDEEN, DEBORAH B. ROLKA |
| 81 |
[GO] |
2023―Jun―20 |
1002-P: Health Care Utilization among Telehealth Users and Nonusers with Diabetes during the COVID-19 Pandemic-Results from National Medicare Claims |
YIXUE SHAO, YU WANG, XILIN ZHOU, DEBORAH B. ROLKA, PING ZHANG |
| 82 |
[GO] |
2023―Jun―20 |
1172-P: The Social Impact of COVID-19 Pandemic on Children with Diabetes |
RUBA ABDUL WAHED, SARAH RONIS, SARAH A. MACLEISH, JAMIE R. WOOD, SINDHOOSHA MALAY, KATHERINE A. KUTNEY |
| 83 |
[GO] |
2023―Jun―20 |
1194-P: Impact of COVID-19 on Gestational Diabetes Mellitus (GDM) Screening and Outcomes |
VICHY LIYANAGE, OLESYA BARRETT, DELIWE P. NGWEZI, ANAMARIA SAVU, ROSEANNE O. YEUNG, SONIA BUTALIA, PADMA KAUL |
| 84 |
[GO] |
2023―Jun―20 |
192-LB: Temporal Relationship of New Pediatric Diabetes Diagnoses and COVID-19 |
NEHA REDDY, STEVE JOHNSON, RICHARD A. MOFFITT, MICHAEL EVANS, HSIN-CHIEH YEH, JANE E.B. REUSCH, RACHEL WONG, JOHN B. BUSE, CAROLYN BRAMANTE, JEREMY HARPER |
| 85 |
[GO] |
2023―Jun―20 |
673-P: Youth with Type 1 Diabetes and Elevated A1C during the Coronavirus Disease-2019 (COVID-19) Pandemic-Examination of Family, Caregiver, and Medical Team Factors |
DAVID V. WAGNER, MEGAN PERRY, MARK A. CLEMENTS, JENISE C. WONG, DIANA NARANJO, ALISON REED, CELESTE JENISCH, CRISTIAN CRUZ, SUSANNE MITCHELL, LOREN YGLECIAS, JAQUELIN FLORES GARCIA, ALEJANDRA TORRES SANCHEZ, ANDREA BONILLA OSPINA, JENNIFER RAYMOND, MICHAEL A. HARRIS |
| 86 |
[GO] |
2023―Jun―20 |
135-LB: A Variable Impact of the Wave 1 and Wave 2 Lockdowns of the COVID-19 Pandemic on Glycemic Control-A Longitudinal Analysis of FGM Adult Users From Poland |
JERZY HOHENDORFF, KALVIN KAO, LAURA BRANDNER, MACIEJ MALECKI |
| 87 |
[GO] |
2023―Jun―20 |
35-LB: The Impact of the COVID-19 Pandemic on A1C Reductions in Patients with Diabetes Mellitus Who Attended an ADA-Recognized DSMES Program |
KENT B. STONEKING, KASHIF LATIF, MARIAN MOORE, HANNAH WHITE |
| 88 |
[GO] |
2023―Jun―20 |
678-P: Impact of COVID-19 on Black Youth with T1D and Their Parents |
KELSEY R. HOWARD, MARISSA FELDMAN, APRIL I. CARCONE, KIMBERLY P. GARZA, MEREDYTH A. EVANS, JILL WEISSBERG-BENCHELL, DEBORAH A. ELLIS |
| 89 |
[GO] |
2023―Jun―20 |
1486-P: Effects of the COVID-19 Booster Vaccine on Glycemia and Insulin Resistance in People with Type 1 Diabetes-A Prospective Pilot Study |
MIHAIL ZILBERMINT, MAHSA MOTEVALLI, KRISTINE BATTY, JEMILA VENNER-WALCOTT, ALEXIS EDWARDS, TANYA BURLEY, KEITH JACKSON, MAHRUKH AKHTAR, ANDREW DEMIDOWICH |
| 90 |
[GO] |
2023―Jun―20 |
745-P: The Impact of COVID-19 and the Public Health Emergency on the Medicare Diabetes Prevention Program |
SARA JACOBS, THOMAS J. HOERGER, BENJAMIN T. ALLAIRE, PETER AMICO, PATRICIA MARKOVICH, MELISSA ROMAIRE |
| 91 |
[GO] |
2023―Jun―20 |
1436-P: Glycemic Variability as a Risk Factor for In-Hospital Mortality among CKD, Type 2 DM Patients Admitted for COVID-19-Retrospective Cohort Study |
NOREEN ADA G. MANGUGAN |
| 92 |
[GO] |
2023―Jun―20 |
1116-P: Increase in the Incidence of Type 2 Diabetes in Children <11 Years during the COVID-19 Pandemic |
SABITHA SASIDHARAN PILLAI, PHINNARA HAS, LISA S. TOPOR, MEGHAN E. FREDETTE |
| 93 |
[GO] |
2023―Jun―20 |
656-P: COVID-19 Exposure and Perceived Impact Associated with Poor Psychosocial, Behavioral, and Physical Health |
JOYCE YI-FRAZIER, MAEVE B. O'DONNELL, BRITNEY M. ELLISOR, SAMANTHA GARCIA PEREZ, FAISAL MALIK, YULIANA ROJAS, DANIEL DESALVO, CATHERINE PIHOKER, SAMANTHA R. SCOTT, MIRANDA BRADFORD, CHUAN ZHOU, ABBY ROSENBERG, MARISA E. HILLIARD |
| 94 |
[GO] |
2023―Jun―20 |
768-P: Effect of Dulaglutide Therapy Initiation on the Course of Coronavirus Infection and the Dynamics of Inflammatory Markers in Hospitalized Patients with Type 2 Diabetes |
TATIANA MARKOVA, MUKHAMED STAS, ANASTASIA ANCHUTINA |
| 95 |
[GO] |
2023―Jun―20 |
1394-P: Risk for Newly Diagnosed Type 2 Diabetes Mellitus after SARS-CoV-2 Infection among Korean Adults-A Nationwide Matched Cohort Study |
JONG HAN CHOI, KEE-HO SONG |
| 96 |
[GO] |
2023―Jun―20 |
22-OR: High Glucose Metabolism Fuels Cathepsin L Maturation to Promote SARS-CoV-2 Infection in Patients with Diabetes |
MIAOMIAO ZHAO, QIONG HE, JIN-KUI YANG |
| 97 |
[GO] |
2023―Jun―20 |
1007-P: Employment and Work Conditions among U.S. Adults with Diagnosed Diabetes Pre- and Post-COVID-19 Pandemic |
SHICHAO TANG, YU CHEN, PING ZHANG |
| 98 |
[GO] |
2023―Jun―20 |
147-LB: Visits in Pediatric vs. Adult Clinics for Young Adults (YA) with T1D-Prepandemic and Pandemic Care |
AMIT SHAPIRA, LIANE J. TINSLEY, ELENA TOSCHI, LORI M. LAFFEL |
| 99 |
[GO] |
2023―Jun―20 |
315-OR: Diabetes and Dyslipidemia in Young, a Hidden Pandemic-Real-World Multicentric Study from India |
ASHISH K. SAXENA, MEENAKSHISUNDARAM LAKSHMANAN, AASHNA PATIL, NAGENDRA K. SINGH, ANUJ MAHESHWARI, MUKULESH GUPTA, BIJAY PATNI, DINESH KUMAR, VINAYAK S. HIREMATH, S S. DARIYA, SURAJEET K. PATRA, RAKA SHEOHARE, MOHSIN ASLAM, RAMA REGULLA, RAGHUNATH DANTU |
| 100 |
[GO] |
2023―Jun―20 |
1419-P: Pandemic-Specific Associations of Maternal Exposure to Per- and Polyfluoroalkyl Substances and Glucose Metabolisms-A Cross-Sectional Analysis in Birth Cohort in Hong Kong |
AIMIN YANG, CLAUDIA H. TAM, RISA OZAKI, WILLIAM L. LOWE, BOYD E. METZGER, WING H. TAM, CHRIS K. WONG, RONALD C. MA |
| 101 |
[GO] |
2023―Apr―20 |
Increased Risk of Diabetes and Diabetic Ketoacidosis Associated With COVID-19 |
Laura Montefusco, Ida Pastore, Maria Elena Lunati, Paolo Fiorina |
| 102 |
[GO] |
2022―Nov―21 |
COVID-19 and Incident Type 1 Diabetes: Deciphering the Associations |
Shivani Misra, Linda A. DiMeglio |
| 103 |
[GO] |
2022―Nov―21 |
Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2- Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656-2663 |
Massimo Pietropaolo, Peter Hotez, Nick Giannoukakis |
| 104 |
[GO] |
2022―Nov―21 |
Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2-Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656-2663 |
Chi-Kuei Hsu, Chih-Cheng Lai |
| 105 |
[GO] |
2022―Oct―10 |
Causal Associations Between Basal Metabolic Rate and COVID-19 |
Ancha Baranova, Yuqing Song, Hongbao Cao, Fuquan Zhang |
| 106 |
[GO] |
2022―Sep―15 |
Impacts of COVID-19 on Glycemia and Risk of Diabetic Ketoacidosis |
Anukriti Sharma, Anita D. Misra-Hebert, Arshiya Mariam, Alex Milinovich, Anthony Onuzuruike, Wilhemina Koomson, Michael W. Kattan, Kevin M. Pantalone, Daniel M. Rotroff |
| 107 |
[GO] |
2022―Sep―12 |
Incidence Trends of New-Onset Diabetes in Children and Adolescents Before and During the COVID-19 Pandemic: Findings from Florida |
Yi Guo, Jiang Bian, Aokun Chen, Fei Wang, Amanda L. Posgai, Desmond A. Schatz, Elizabeth A. Shenkman, Mark A. Atkinson |
| 108 |
[GO] |
2022―Aug―19 |
Response to Comment on D’Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806 |
Francesca D’Addio, Paolo Fiorina |
| 109 |
[GO] |
2022―Aug―19 |
Comment on D’Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806 |
Pathum Sookaromdee, Viroj Wiwanitkit |
| 110 |
[GO] |
2022―May―31 |
266-OR: Dexamethasone-Induced Hyperglycemia in Nondiabetic Patients with COVID-19 |
YOON JI J. RHOU, AMANDA HOR, MAWSON WANG, YU-FANG WU, DAVID R. CHIPPS, N. WAH CHEUNG |
| 111 |
[GO] |
2022―May―31 |
263-OR: Glycemic Gap Predicts Mortality in a Large Multicenter Diabetes Cohort Hospitalized with COVID-19 |
MARIE E. MCDONNELL, DONALD C. SIMONSON, GEETHA GOPALAKRISHNAN, RAJESH GARG, JOANNA MITRI, RUTH S. WEINSTOCK, MARGARET GREENFIELD, NADINE E. PALERMO, RAMYA RADHAKRISHNAN, GREGORY P. WESTCOTT |
| 112 |
[GO] |
2022―May―31 |
267-OR: Diabetes, COVID-19, and All-Cause Mortality among People with Diabetes during the COVID-Pandemic in Minnesota: Population-Based Study |
ROZALINA G. MCCOY, AIDAN F. MULLAN, MOLLY M. JEFFERY, COLIN M. BUCKS, CASEY M. CLEMENTS, RONNA CAMPBELL |
| 113 |
[GO] |
2022―May―31 |
186-LB: Relationship of the Diagnosis of Diabetes Mellitus (DM) and Hyperglycemia without DM Diagnosis at Hospital Admission with the Evolution of Patients Hospitalized for COVID-19 in a Private Hospital Center in Asunción-Paraguay |
MARIA G. CANATA, SERGIO A. LOGWIN, ELVIO D. BUENO COLMAN, ALDO BENITEZ, ARIEL J. FRETES, GERARDO BRUNSTEIN DIEZ PEREZ, CLAUDIA BORDON, JORGE T. JIMENEZ, MAFALDA PALACIOS |
| 114 |
[GO] |
2022―May―31 |
168-LB: Presentation of New Onset Diabetes in Youth during the COVID-19 Pandemic |
KATE CITRON, CHERYL R. STEIN, JENIECE ILKOWITZ, JUANA E. GONZALEZ, VANESSA JOSEPH, MARY PAT GALLAGHER |
| 115 |
[GO] |
2022―May―31 |
146-LB: Impact of the COVID-19 Pandemic on Quality of Life in Youth with Type 1 Diabetes |
ERIN C. COBRY, LAURA PYLE, TIMOTHY B. VIGERS, LUKE GEISER, LISA J. MELTZER |
| 116 |
[GO] |
2022―May―31 |
147-LB: Effects of the COVID-19 Pandemic on Type 1 Diabetes Outcomes |
LUKE GEISER, LAURA PYLE, TIMOTHY B. VIGERS, LISA J. MELTZER, ERIN C. COBRY |
| 117 |
[GO] |
2022―May―31 |
1016-P: Equitable Glycemic Improvement in Youth with T1D during COVID-19 |
SANDO OJUKWU, ATIF ADAM, TARA KAUSHAL, LIANE J. TINSLEY, LISA K. VOLKENING, CHARLOTTE CHEN, LORI M. LAFFEL |
| 118 |
[GO] |
2022―May―31 |
1235-P: A Prospective Characterization of Metabolic and Metabolomic Profiles of COVID-19-Associated New-Onset Diabetes Patients Presenting with DKA from India |
RIDDHI DASGUPTA, S MONDAL, R GARAI, B CHOWDHURY, A HAZRA, M LODH, A GANGULY |
| 119 |
[GO] |
2022―May―31 |
153-LB: Type 1 Diabetes (T1D) Onset and COVID-19-Effect of the Second Wave on Diabetes Ketoacidosis and ICU Admission Rates in Newly Diagnosed Children with T1D in Kuwait |
FOUZEYAH OTHMAN, DALIA AL-ABDULRAZZAQ, HESSA ALKANDARI |
| 120 |
[GO] |
2022―May―31 |
589-P: Health Disparities among People with and without Diabetes during COVID-19: An 18-Month Evaluation |
BARBARA A. MYERS, RACHEL KLINGENSMITH, INES GONZALEZ CASANOVA, MARY DE GROOT |
| 121 |
[GO] |
2022―May―31 |
623-P: COVID-Impact on Type 2 Diabetes Self-Management during the Pandemic |
LEIGH ANNE KOONMEN, TERRY A. LENNIE, MELINDA ICKES, LAURA B. HIERONYMUS, JENNIFER L. MILLER, GIA MUDD-MARTIN |
| 122 |
[GO] |
2022―May―31 |
943-P: Impact of Culturally Appropriate Diabetes Care amongst Asian Americans with Type 2 Diabetes during the COVID Pandemic |
ATIF ADAM, KA HEI KAREN LAU, HETAL SHAH, MARC GREGORY YU, GEORGE L. KING |
| 123 |
[GO] |
2022―May―31 |
163-LB: Impact of Preexisting Type 2 Diabetes (T2D) and Concurrent Cardiovascular Disease (CVD) on Patients with COVID-19 (C-19) |
CHI NGUYEN, CHRISTOPHER CROWE, EFFIE KUTI, NIHAL NARSIPUR, BONNIE M.K. DONATO, REBECCA S. PEPE, RACHEL L. DJARAHER, LEO J. SEMAN, NANCY GRAETER, THOMAS P. POWER, RINKU MEHRA, VINCENT WILLEY |
| 124 |
[GO] |
2022―May―31 |
67-LB: Nursing Perspectives on Hospital Use of Dexcom Continuous Glucose Monitor in Patients with Suspected or Known COVID-19 during Insulin Infusion |
JILLIAN PATTISON, KATHLEEN M. DUNGAN, ELIZABETH BUSCHUR, MATTHEW C. EXLINE, LAUREEN G. JONES, CASEY MAY, MOLLY MCNETT, KEATON SMETANA, EILEEN R. FAULDS |
| 125 |
[GO] |
2022―May―31 |
241-LB: Significant Worsening of Preexisting Obesity in South Texas Children during COVID-19 Lockdown |
FRANCISCO J. CERVANTES |
| 126 |
[GO] |
2022―May―31 |
89-LB: COVID-19 Outcomes in Patients Who Started GLP1-RAs during Hospitalization |
VINCENZO PROVENZANO, DAVIDE BRANCATO, MATTIA FLERES, FRANCESCA PROVENZANO, ANNA R. SALVAGGIO, ALESSANDRO SCORSONE |
| 127 |
[GO] |
2022―May―31 |
34-LB: Feasibility of Onboarding and Supporting Diabetes Technologies in Youth with Type 1 Diabetes during the COVID-19 Pandemic and Beyond |
MARGARET PELLIZZARI, JOANNA FISHBEIN, GRAEME FRANK, BENJAMIN U. NWOSU |
| 128 |
[GO] |
2022―May―31 |
165-LB: The Impact of COVID-19 Vaccination on Development of Hyperglycemic Crisis |
KATHERINE L. MODZELEWSKI, SARA ALEXANIAN |
| 129 |
[GO] |
2022―May―31 |
155-LB: Evaluating Community COVID-19 Vaccination Status and Diabetes Visit Frequency during the Pandemic |
SANDO OJUKWU, ATIF ADAM, TARA KAUSHAL, CHARLOTTE CHEN, LIANE J. TINSLEY, LISA K. VOLKENING, LORI M. LAFFEL |
| 130 |
[GO] |
2022―May―31 |
176-LB: Metformin Use among Hospitalized Patients with Diabetes and COVID-19-Clinical Characteristics and Outcomes from a Multiracial, Multiethnic Urban Cohort |
EMILY MIAO, KALEENA ZHANG, JIANYOU LIU, JUAN LIN, CLAUDENE GEORGE |
| 131 |
[GO] |
2022―May―31 |
1430-P: Association of Obesity and Diabetes with SARS-Cov-2 Infection and Symptoms |
MORGANA MONGRAW-CHAFFIN, ASHLEY H. TJADEN, AUSTIN SEALS, KRISTEN MILLER, NAHEED AHMED, MARK ESPELAND, MICHAEL A. GIBBS, DIANE USCHNER, WILLIAM S. WEINTRAUB, SHARON EDELSTEIN |
| 132 |
[GO] |
2022―May―31 |
1391-P: Reduced DMPC and PMPC in Lung Surfactant Promotes SARS-CoV-2 Infection in Obesity |
KANG DU, LING SUN, ZICHEN LUO, YANG CAO, JINJUN SHAN, QIN YANG |
| 133 |
[GO] |
2022―May―31 |
34-OR: SARS-CoV-2 Infection Is Not Associated with Presence of Islet Autoantibodies in Children: Autoimmunity Screening for Kids (ASK) |
CRISTY GENO RASMUSSEN, XIAOFAN JIA, HANAN SHORROSH, LIPING YU, BRIGITTE I. FROHNERT, KIMBER M. SIMMONS, ANDREA STECK, LAURA PYLE, MARIAN REWERS |
| 134 |
[GO] |
2022―May―31 |
175-LB: Patient Determinants of Mortality with Severe DKA and/or HHS during the COVID Pandemic Differ from the Prepandemic |
ALMIRA J. YANG, MATTHEW A. FIREK, IQBAL MUNIR, ANH TRAN, ANTHONY FIREK |
| 135 |
[GO] |
2022―May―31 |
1014-P: Characteristics Associated with Diabetes Device Use Before and During the Pandemic in Youth with T1D |
CHARLOTTE CHEN, ATIF ADAM, SANDO OJUKWU, TARA KAUSHAL, LIANE J. TINSLEY, LISA K. VOLKENING, LORI M. LAFFEL |
| 136 |
[GO] |
2022―May―31 |
169-OR: Census Tract SES Coding to Assess Impact of the Pandemic on Care of Youth with T1D |
ATIF ADAM, CHARLOTTE CHEN, SANDO OJUKWU, TARA KAUSHAL, LIANE J. TINSLEY, LISA K. VOLKENING, LORI M. LAFFEL |
| 137 |
[GO] |
2022―May―31 |
1419-P: Insulin Resistance Predicts Severe Acute COVID-and Long COVID |
EKREM M. AYHAN, SHU CAO, OLIVIA RAEBER, SHARON CHINTHRAJAH, KARI NADEAU, TRACEY MCLAUGHLIN |
| 138 |
[GO] |
2022―May―31 |
1166-P: Distinct Phenotypes of Multiorgan Abnormalities in Long COVID and Type 2 Diabetes Identified by Multiparametric Magnetic Resonance Imaging |
NICOLE EICHERT, ALISON TELFORD, ADRIANA ROCA-FERNANDEZ, AZLINDA HAMID, HELENA B. THOMAIDES-BREARS, ANDREA DENNIS, RAJARSHI BANERJEE, SARAH ALI, GAYA THANABALASINGHAM, GRAHAM KEMP, DANIEL CUTHBERTSON, AMITAVA BANERJEE |
| 139 |
[GO] |
2022―May―12 |
Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes |
Francesca D'Addio, Gianmarco Sabiu, Vera Usuelli, Emma Assi, Ahmed Abdelsalam, Anna Maestroni, Andy Joe Seelam, Moufida Ben Nasr, Cristian Loretelli, Davide Mileto, Giada Rossi, Ida Pastore, Laura Montefusco, Paola S. Morpurgo, Laura Plebani, Antonio Rossi, Enrica Chebat, Andrea M. Bolla, Elena Lunati, Chiara Mameli, Maddalena Macedoni, Spinello Antinori, Stefano Rusconi, Maurizio Gallieni, Cesare Berra, Franco Folli, Massimo Galli, Maria Rita Gismondo, Gian Vincenzo Zuccotti, Paolo Fiorina |
| 140 |
[GO] |
2022―May―02 |
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets |
Moufida Ben Nasr, Francesca D’Addio, Laura Montefusco, Vera Usuelli, Cristian Loretelli, Antonio Rossi, Ida Pastore, Ahmed Abdelsalam, Anna Maestroni, Marco Dell’Acqua, Elio Ippolito, Emma Assi, Andy Joe Seelam, Roberta Maria Fiorina, Enrica Chebat, Paola Morpurgo, Maria Elena Lunati, Andrea Mario Bolla, Reza Abdi, Joseph V. Bonventre, Stefano Rusconi, Agostino Riva, Domenico Corradi, Pierachille Santus, Pamela Clark, Manuela Nebuloni, Gabriella Baldi, Giovanna Finzi, Franco Folli, Gian Vincenzo Zuccotti, Massimo Galli, Kevan C. Herold, Paolo Fiorina |
| 141 |
[GO] |
2022―Jan―21 |
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 |
Benedetta Maria Bonora, Paola Fogar, Jenny Zuin, Daniele Falaguasta, Roberta Cappellari, Annamaria Cattelan, Serena Marinello, Anna Ferrari, Angelo Avogaro, Mario Plebani, Daniela Basso, Gian Paolo Fadini |
| 142 |
[GO] |
2021―Oct―22 |
COVID-19-Induced New-Onset Diabetes: Trends and Technologies |
Ahmed A. Metwally, Pranav Mehta, Brian S. Johnson, Anvith Nagarjuna, Michael P. Snyder |
| 143 |
[GO] |
2021―Oct―06 |
Possible Involvement of Adipose Tissue in Older and Obese Diabetic Patients with Coronavirus SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19 |
Jihoon Shin, Shinichiro Toyoda, Shigeki Nishitani, Atsunori Fukuhara, Shunbun Kita, Michio Otsuki, Iichiro Shimomura |
| 144 |
[GO] |
2021―Sep―27 |
Diabetes, Drug Treatment and Mortality in COVID-19: A Multinational Retrospective Cohort Study |
Jennifer E. Nyland, Nazia T. Raja-Khan, Kerstin Bettermann, Philippe A. Haouzi, Douglas L. Leslie, Jennifer L. Kraschnewski, Leslie J. Parent, Patricia Sue Grigson |
| 145 |
[GO] |
2021―Jun―24 |
361-P: Elevated BNP Is Associated with Higher Risk of Cardiac Arrest in Diabetic Patients Hospitalized with COVID-19 |
AWFA ZAIN ELABIDIN, LEANNE PEREIRA, VAHID NAMDARIZANDI, MICHAEL FATUYI, SHALEMAR ANN KASAN, VIVEK SHARMA, BASSMAN TAPPUNI, BELAL KASEER, DOMINIQUE M. BRANDT, KAMAL SHEMISA |
| 146 |
[GO] |
2021―Jun―24 |
172-LB: Identification of Specific Risk Factors for Mortality in Patients with Diabetes Mellitus Hospitalized with COVID-19 |
PEDRO J. PINÉS-CORRALES, MARIA MOLINA, LOURDES GARCÍA-BLASCO, ROSA QUILEZ TOBOSO, MARINA ALCARAZ, LUIS VICENTE GUTIÉRREZ, GEMA PATERNA MELLINAS, JUAN MARIA CALBO MAYO, JOSÉ-JOAQUÍN ALFARO-MARTÍNEZ |
| 147 |
[GO] |
2021―Jun―24 |
1009-P: A Comparison of Hyperglycemic Crises in Patients with and without COVID-19 |
ARNAV A. SHAH, ELAYNA SILFANI, ANDREW DEAK, CHRISTINA KOPPIN, SHANEISHA ALLEN, YAARA ZISMAN-ILANI, CHRISTINA ROSE, IMALI SIRISENA, DANIEL J. RUBIN |
| 148 |
[GO] |
2021―Jun―24 |
1014-P: The Impact of Baseline A1C and Admission Glucose on Mortality among Patients with Diabetes Hospitalized with COVID-19 |
JOSEPH BRANCALE, DIANA ATHONVARANGKUL, MICHAEL SIMONOV, JAMEEL ALAUSA, LABEEBAH K. SUBAIR, ALEXANDRA M. HAJDUK, YU MI KANG, TANIMA ARORA, FRANCIS P. WILSON, ANIA M. JASTREBOFF, KASIA J. LIPSKA |
| 149 |
[GO] |
2021―Jun―24 |
74-LB: Sudden Changes in Interstitial Glucose Sensing by Remote Real-Time Continuous Glucose Monitoring as a Marker of Hypoperfusion in Critically-Ill Patients with COVID-19 |
JOI HESTER, GEORGIA M. DAVIS, FRANCISCO J. PASQUEL, MARINA RABINOVICH, NORMA POINDEXTER, SEEMA TEKWANI |
| 150 |
[GO] |
2021―Jun―24 |
296-OR: Metabolic Syndrome Is Associated with a Longer Complicated ICU Stay and Greater Mortality in Patients Hospitalized with COVID-19 |
LEANNE PEREIRA, VAHID NAMDARIZANDI, SHALEMAR ANN KASAN, MICHAEL FATUYI, BASSMAN TAPPUNI, BELAL KASEER, DOMINIQUE M. BRANDT, KAMAL SHEMISA, AWFA ZAIN ELABIDIN, VIVEK SHARMA |
| 151 |
[GO] |
2021―Jun―24 |
541-P: Social and Biological Risk Factors Threaten Hispanics/Latinos with Type 2 Diabetes, Now at Risk for COVID-19 |
NAMINO M. GLANTZ, ROSIRENE PACZKOWSKI, ARIANNA J. LAREZ, FELICIA GELSEY, BANRUO YANG, BRIAN D. BENNEYWORTH, DAVID KERR |
| 152 |
[GO] |
2021―Jun―24 |
826-P: Application of Health Services Outcome Research Approaches to Refine Pragmatic Trial Design during COVID-19 |
PAMELA WAX, REBECA KHORZAD, CHEONG M. YU, EMILIE K. TOUMA, AMADOR ROSALES, GRACE PRINCE, KASEY COYNE, STACY BAILEY, TERESA POLLACK, CYNTHIA BARNARD, RONALD T. ACKERMANN, JANE L. HOLL, AMISHA WALLIA |
| 153 |
[GO] |
2021―Jun―24 |
1277-PUB: Severe DKA in Adolescent at Onset of Type 2 Diabetes and COVID-19 |
MERILYN BABY, MELISSA KAORI S. LITAO, HEDA R. DAPUL, BONITA FRANKLIN, MARY PAT GALLAGHER |
| 154 |
[GO] |
2021―Jun―24 |
145-LB: Glycemic Control Is Not an Independent Predictor of Mortality or Length of Stay for Patients Hospitalized with Coronavirus 2019 (COVID-19) |
MICHAEL G. JAKOBY, VANESSA WILLIAMS, STACEY WARD, SCOTT K. LEE, MICHAEL BUHNERKEMPE, KENNETH IZUORA |
| 155 |
[GO] |
2021―Jun―24 |
627-P: Uncontrolled Hyperglycemia Predicts Ventilatory Support and Duration of Hospital Stay in People with Diabetes and COVID-19 |
SOUMYABRATA ROY CHAUDHURI, ANIRBAN MAJUMDER, DEBMALYA SANYAL, AJOY BISWAS, KINGSHUK BHATTACHARJEE |
| 156 |
[GO] |
2021―Jun―24 |
976-P: Cardiovascular Risk Predicts Severe Respiratory Failure in Patients Hospitalized with COVID-19 |
SAM LOCKHART, ANUM SHEIKH, HARY GRIFFITHS, JULIA CALVO LATORRE, AIDEEN B. DALY, LATIKA SIBAL |
| 157 |
[GO] |
2021―Jun―24 |
93-LB: Comparison of Glycemic Control between Multiple Daily Injections and Hybrid Closed-Loop System in Children and Adolescents during the Restrictions Due to COVID-19 |
GORAN PETROVSKI, JUDITH CAMPBELL, KHALID HUSSAIN |
| 158 |
[GO] |
2021―Jun―24 |
1017-P: Association between Death at Day 28 and Components of Microvascular Disease of with Diabetes Hospitalized for Coronavirus Disease-2019 (COVID-19): The CORONADO Study |
PIERRE-JEAN SAULNIER, SAMY HADJADJ, LAURENCE KESSLER, MICHEL MARRE, JEAN MICHEL HALIMI, MATTHIEU WARGNY, PIERRE GOURDY, BERTRAND CARIOU |
| 159 |
[GO] |
2021―Jun―24 |
1023-P: Interaction of COVID-19 and Preexisting Diabetes on Hospital Presentation of Diabetic Ketoacidosis |
JUSTIN MATHEW, CLYDE SCHECHTER, WILLIAM SOUTHERN, JILL P. CRANDALL, YARON TOMER, SHIVANI AGARWAL |
| 160 |
[GO] |
2021―Jun―24 |
1044-P: COVID-19 and Trends in Emergency Room (ER) Admissions for Diabetic Ketoacidosis (DKA) and Hypoglycemia |
YU KUEI LIN, CAROLINE R. RICHARDSON, SIMON FISHER, GRETCHEN PIATT, RODICA POP-BUSUI |
| 161 |
[GO] |
2021―Jun―24 |
901-P: COVID-19 and Type 2 Diabetes: Children Spared from Severe Disease Course |
ANNA CYMBALUK, MARCELA ASTUDILLO, DANIEL DESALVO, FIDA BACHA, SIRIPOOM MCKAY, MARIA J. REDONDO |
| 162 |
[GO] |
2021―Jun―24 |
1113-P: COVID-19 Avoidance Behaviors in Adults with Type 1 Diabetes |
CATHERINE J. CHARTIER-LOGAN, EMMA EIKERMANN, HALEY K. WISE, EMILY MALECHA, JANET K. SNELL-BERGEON |
| 163 |
[GO] |
2021―Jun―24 |
1021-P: Mortality and Length of Hospitalisation amongst Diabetic and Nondiabetic COVID-19 Critical Patients: A Retrospective Cohort Study |
AJAY K. SINHA, DIVYANSHU PANDEY, MAJOR MADHUKAR, ROSHAN K. TOPNO, RISHIKESH KUMAR, SANJAY K. SINHA |
| 164 |
[GO] |
2021―Jun―24 |
146-LB: Association of Serum 1,5-Anhydroglucitol with Severe COVID-19 in T2D patients |
GAZTAMBIDE SONIA, ERIC A. BUTTON, MIRELLA ZULUETA, EUNATE ARANA, ANA B. DE LA HOZ, LEIRE MENDIZABAL, JUAN DEL OLMO, RAQUEL MUÑOZ, LAUREANO SIMON, LUIS CASTANO |
| 165 |
[GO] |
2021―Jun―24 |
1235-P: Metabolic Syndrome Is a Risk Factor for Hospitalization and Mortality from COVID-19 Independent of Other Comorbidities |
SHANNON WU, JAMES F. BENA, KEREN ZHOU, ANITA D. MISRA-HEBERT, SANGEETA KASHYAP |
| 166 |
[GO] |
2021―Jun―24 |
175-LB: Stress Hyperglycemia Predicts Mechanical Ventilation and Death in COVID-19 Infected Adults |
MARIE E. MCDONNELL, DONALD C. SIMONSON, GRACE CROMWELL, GEETHA GOPALAKRISHNAN, MARGARET GREENFIELD, MATTHEW JOHNSON, SAI R. KATTA, JASMIN LEBASTCHI, JOANNA MITRI, NADINE E. PALERMO, RAMYA RADHAKRISHNAN, GREGORY P. WESTCOTT, RUTH S. WEINSTOCK, RAJESH GARG |
| 167 |
[GO] |
2021―Jun―24 |
1098-P: Admission Blood Glucose but Not HbA1c Predicts Mortality in People with Diabetes Hospitalized with COVID-19 Infection |
SOUMYABRATA ROY CHAUDHURI, ANIRBAN MAJUMDER, DEBMALYA SANYAL, AJOY BISWAS, KINGSHUK BHATTACHARJEE |
| 168 |
[GO] |
2021―Jun―24 |
176-LB: The Impact of COVID-19 Infection on Subsequent Glycemic Control |
EMILIA G. THURBER, MARIE E. MCDONNELL, GRACE CROMWELL, MATTHEW JOHNSON, DONALD C. SIMONSON, NADINE E. PALERMO |
| 169 |
[GO] |
2021―Jun―24 |
885-P: C-Reactive Protein Predicts COVID-19 Infection Severity and Length of Hospitalization |
HELEN KREIT, SUNDAR V. CHERUKURI, ROSHNI A. MANDANIA, ABHIZITH DEOKER, AKSHAY A. GUPTE, ALI MOSSAYEBI, JEANNIE B. CONCHA, HYEJIN JUNG, AMY E. WAGLER, SUDIP BAJPEYI |
| 170 |
[GO] |
2021―Jun―24 |
1007-P: Risk Factor for COVID-19 Infection-Related Hospitalization in Patients with Type 2 Diabetes |
TAKESHI HORII, WATARU ANDO, KATSUYA OTORI, KOICHIRO ATSUDA |
| 171 |
[GO] |
2021―Jun―24 |
468-P: Impact of Webinars and Telemedicine during COVID-19 Lockdown in Transforming Outcomes in 848 T2D Patients in India |
JOTHYDEV KESAVADEV, BANSHI D. SABOO, ARUN SHANKAR, GOPIKA KRISHNAN, ANJANA BASANTH, SANTHI JYOGESH, SANAL T.S., GOPIKA B. CHANDRAN, KRISHNADEV JOTHYDEV, SUNITHA JOTHYDEV |
| 172 |
[GO] |
2021―Jun―24 |
185-LB: Effect of the COVID-19 Lockdown on Glycemic Control in Adult Patients with Type 2 Diabetes Mellitus |
IS-HAQ O. MALIK, KAMRUN NAHER, KOMANDUR THRUPTHI, BUSHRA ZAIDI, VIVIEN LEUNG |
| 173 |
[GO] |
2021―Jun―24 |
156-LB: Family Exposure and Impact of COVID-19 on a Pediatric T1D Population |
ERIN C. COBRY, TIMOTHY B. VIGERS, LAURA PYLE, LISA J. MELTZER |
| 174 |
[GO] |
2021―Jun―24 |
578-P: Impact of COVID-19 on Diabetes Self-Management and Care |
MARGARET ZUPA, STEPHANIE PEREZ, GLORIA PALMISANO, EDITH C. KIEFFER, GRETCHEN PIATT, FELIX VALBUENA, DENISE J. DEVERTS, JONATHAN YABES, MICHELE HEISLER, ANN-MARIE ROSLAND |
| 175 |
[GO] |
2021―Jun―24 |
523-P: Psychosocial Impact of COVID-19 on Pediatric Diabetes |
KAREN DIMENTSTEIN, SHANIQUE YEE, JESSICA M. VALENZUELA, BERNARD PAN, MEG SNYDER, RISA WOLF |
| 176 |
[GO] |
2021―Jun―24 |
862-P: Impact of COVID-19 on Pediatric Endocrinology Practice and Diabetes Care in Children: A Survey |
MELISSA CHAMBERS, MADHUMITA SINHA |
| 177 |
[GO] |
2021―Jun―24 |
935-P: Favorable Shift in CGM Glucose in Youth with T1D during COVID-19 Pandemic |
TARA KAUSHAL, LIANE J. TINSLEY, LISA K. VOLKENING, LOUISE AMBLER-OSBORN, LORI M. LAFFEL |
| 178 |
[GO] |
2021―Jun―24 |
545-P: Experiences of Emerging Adults with T1D during the COVID-19 Pandemic |
MAUREEN MONAGHAN, BREANA BRYANT, CHRISTINE H. WANG |
| 179 |
[GO] |
2021―Jun―24 |
547-P: Worry and Mental Health in Young Adults with Type 1 Diabetes during the COVID-19 Pandemic |
PERSIS V. COMMISSARIAT, DANIELLE ST. PIERRE, ANNA SABINO, SARA LEE, JENNIFER SAYLOR |
| 180 |
[GO] |
2021―Jun―24 |
543-P: Challenges in Glucose Management in Young Adults during the COVID-19 Pandemic |
JENNIFER SAYLOR, SARA LEE, PERSIS V. COMMISSARIAT, ANNA SABINO, DANIELLE ST. PIERRE |
| 181 |
[GO] |
2021―Jun―24 |
838-P: Current Provision and HCP Experiences of Remote Care Delivery and Diabetes Technology Training for People with Type 1 Diabetes in the UK during the COVID-19 Pandemic |
HANNAH E. FORDE, PRATIK CHOUDHARY, SUFYAN HUSSAIN |
| 182 |
[GO] |
2021―Jun―24 |
5-OR: Health Disparities in People with and without Diabetes during the COVID-19 Pandemic |
BARBARA A. MYERS, RACHEL KLINGENSMITH, MARY DE GROOT |
| 183 |
[GO] |
2021―Jun―24 |
252-OR: Virtual Multidisciplinary Lifestyle Intervention Is as Effective as the Physical Program for Patients with Diabetes and Obesity during COVID-19 Pandemic |
MARWA AL-BADRI, CARA L. KILROY, JACQUELINE I. SHAHAR, SHAHEEN TOMAH, HANNAH GARDNER, MALLORY SIN, JENNIE L. VOTTA, ALIZA PHILLIPS-STOLL, AARON M. PRICE, JOAN M. BEATON, CHANDRA L. DAVIS, JO-ANNE M. RIZZOTTO, OSAMA HAMDY |
| 184 |
[GO] |
2021―Jun―24 |
183-LB: Incidence and Characteristics of Type 1 and Type 2 Diabetes among Youths in the COVID-19 Pandemic |
ANGEL NIP, TARIQ AHMAD |
| 185 |
[GO] |
2021―Jun―24 |
182-LB: Hospitalizations for Hyperglycemic Crisis during COVID-19 Pandemic |
AIMAN RIAZ, CHELSEA GORDNER, ALICE EHRESMAN |
| 186 |
[GO] |
2021―Jun―24 |
153-LB: Initial Presentation of Children with Type 2 Diabetes during the COVID-19 Pandemic |
DANIEL S. HSIA, MARIA LIM, ROBBIE A. BEYL, HIRA A. HASAN, JAMES GARDNER |
| 187 |
[GO] |
2021―Jun―24 |
15-OR: The COVID-19 Pandemic and New-Onset Pediatric Type 2 Diabetes |
BRYNN E. MARKS, ANEKA KHILNANI, ABBY MEYERS, DORIS E. ESTRADA, JENNIFER BOUGHTON, JIAXIANG GAI, RANDI STREISAND, MAUREEN MONAGHAN |
| 188 |
[GO] |
2021―Jun―24 |
309-OR: Mean CGM Values Before and During COVID-19 Pandemic Demonstrate Noninferiority of Telehealth in Pediatric T1D |
TARA KAUSHAL, LIANE J. TINSLEY, LISA K. VOLKENING, CHRISTINE TURCOTTE, LORI M. LAFFEL |
| 189 |
[GO] |
2021―Jun―24 |
102-LB: Six-Month Glycemic Control with a Hybrid Closed-Loop System in Type 1 Diabetes Patients during COVID-19 Pandemic in Argentina |
ADRIAN E. PROIETTI, MARCIAL A. ANGÓS, ALEJANDRO DAIN, MARIELA I. ECHENIQUE, MARÍA L. KABAKIAN, MARIA P. PAZ, MARCELA RAGGIO, GRACIELA B. RUBIN, ANTONIO SALEME, MARIA P. SANTUCCI, MATIAS CASTRO, ANDREA DAGHERO, LUIS A. GROSEMBACHER |
| 190 |
[GO] |
2021―Jun―24 |
137-LB: An Audit on the Management of Diabetic Ketoacidosis during the COVID-19 Pandemic in St. Vincent’s University Hospital, Dublin, Ireland |
A. MARY MCCARTHY, RACHEL CROWLEY |
| 191 |
[GO] |
2021―Jun―24 |
559-P: Impact of COVID-19 Pandemic on Clinical Trial Participation among Young Adults (YA) with Type 1 Diabetes (T1D) |
ELIZABETH PYATAK, AINA ALI, STEFANIE C. KUIZON, ELIA SALAZAR, JEANINE BLANCHARD, ELISSA S. LEE, ELINOR TAYLOR, JENNIFER RAYMOND, D. STEVEN FOX, JOHN SIDERIS, JESUS DIAZ, GABRIELLE GRANADOS, CHERYL VIGEN |
| 192 |
[GO] |
2021―Jun―24 |
872-P: Impact of Telemedicine Consultations during the COVID-19 Pandemic on Glycemic Control of Diabetes Patients |
ASHINI DISSANAYAKE, MONIKA PAWLOWSKA, BENJAMIN SCHROEDER, JESSICA MACKENZIE-FEDER, ADAM WHITE |
| 193 |
[GO] |
2021―Jun―24 |
842-P: Disruption Caused by the COVID-19 Pandemic on HbA1c Testing and Its Implications for Diabetes (DM) Management/Diagnosis |
DAVID HOLLAND, ADRIAN H. HEALD, MICHAEL STEDMAN, LEWIS A. GREEN, JONATHAN SCARGILL, CHRISTOPHER DUFF, FAHMY HANNA, PENSEE WU, ANTHONY A. FRYER |
| 194 |
[GO] |
2021―Jun―24 |
572-P: Impact of Isolation during the COVID-19 Pandemic on the Care of Older Adults with Type 1 Diabetes: A Qualitative Study |
MEDHA MUNSHI, CHRISTINE SLYNE, KAYLA SIFRE, DAI’QUANN J. DAVIS, RACHEL DEWAR, SARAH M. SY, ASTRID ATAKOV-CASTILLO, AMY MICHALS, SAIRA N. HAQUE, SIMON NEUWAHL, STIRLING CUMMINGS, STEPHEN L. BROWN, KATIE WEINGER, ELENA TOSCHI |
| 195 |
[GO] |
2021―Jun―24 |
1275-PUB: Call to Action: COVID-19 Pandemic Prompts Subcutaneous Treatment Option for Diabetes Ketoacidosis (DKA) in Hospital |
DORIS MEEHAN, LAURA TALAVERA, ATHENA PHILIS-TSIMIKAS, ADDIE L. FORTMANN |
| 196 |
[GO] |
2021―Jun―24 |
1110-P: COVID-19 Pandemic-Related Anxiety and Depression Symptoms among Adults with Type 1 Diabetes |
EMILY MALECHA, KIMBERLY A. DRISCOLL, VIRAL SHAH, JANET K. SNELL-BERGEON, CRISTY GENO RASMUSSEN |
| 197 |
[GO] |
2021―Jun―24 |
951-P: Diabetes Management Delivery and Pregnancy Outcomes in Women with Gestational Diabetes Mellitus during the First Wave of the 2020 COVID-19 Pandemic: A Single Reference Centre Report |
MAGDALENA WILK, PAULINA SUROWIEC, BARTłOMIEJ MATEJKO, KATARZYNA CYGANEK, HUBERT HURAS, MACIEJ MALECKI |
| 198 |
[GO] |
2021―Jun―24 |
529-P: Diabetes-Related Distress in Young Adults Prior to and During the COVID-19 Pandemic: Retrospective Self-Reported Data |
DANIELLE ST. PIERRE, PERSIS V. COMMISSARIAT, ANNA SABINO, SARA LEE, JENNIFER SAYLOR |
| 199 |
[GO] |
2021―Jun―24 |
845-P: Unmanaged Diabetes as a Poor Prognostic Factor in the Severity of Infection and Recovery Time of Hospitalized COVID-19 Patients |
ALI MOSSAYEBI, HELEN KREIT, SUNDAR V. CHERUKURI, ROSHNI A. MANDANIA, JEANNIE B. CONCHA, HYEJIN JUNG, AMY E. WAGLER, AKSHAY A. GUPTE, ABHIZITH DEOKER, SUDIP BAJPEYI |
| 200 |
[GO] |
2021―Jun―24 |
1090-P: Diabetes in Japanese COVID-19 Patients as the Primary Factor of Accelerated Progression to Severe State |
SHIZUKA KANEKO, HIDEO KITA, KAZUYA MOTOHASHI, SHINSUKE TOKUMOTO, UEBA YOKO, HIDEKI EGUCHI, ICHIRO TSUNEMATSU |
| 201 |
[GO] |
2021―Jun―24 |
1002-P: HbA1c Level in Severe COVID-19 Patients Is Not Only a Marker of Glycemic Status but Also of Acute Erythrocyte Damage |
MARINA V. SHESTAKOVA, IRINA KONONENKO, ZILYA KALMYKOVA, ANNA ZHELEZNYAKOVA, NATALIA MOKRYSHEVA |
| 202 |
[GO] |
2021―Jun―24 |
873-P: Modified Insulin Infusion Protocol for COVID-19 Patients Is Safe and Effective for Controlling Hyperglycemia |
DIANA ATHONVARANGKUL, LEIGH B. BAK, CINDY ZHENG, JULIE D’AMBROSI, JONATHAN SINER, SHYOKO HONIDEN, SILVIO E. INZUCCHI |
| 203 |
[GO] |
2021―Jun―24 |
181-LB: Hyperglycemia at Hospital Presentation Associated with Severity and Mortality in COVID-19 Patients without Type 2 Diabetes |
NIPITH CHAROENNGAM, MICHAEL F. HOLICK, CAROLINE APOVIAN |
| 204 |
[GO] |
2021―Jun―24 |
723-P: Efficacy and Safety of Once-Daily Fixed-Ratio Coformulation of Degludec-Aspart plus Empa-Lina 25/5 FDC in Post-Discharge COVID-19 Pneumonitis T2DM Patients Treated with Dexamethasone during Inpatient Stay |
SUPRATIK BHATTACHARYYA |
| 205 |
[GO] |
2021―Jun―24 |
40-LB: COVID-19 Severity in a Geographically Diverse, U.S.-based, Ambulatory Population with Type 2 Diabetes on a Medically Supervised Ketogenic Diet |
BRITTANIE M. VOLK, CAROLINE G.P. ROBERTS, MICHELLE VANTIEGHEM, AMY L. MCKENZIE, PATRICIA GEORGE, SHAMINIE J. ATHINARAYANAN, REBECCA N. ADAMS, STEPHEN PHINNEY, ROBERT E. RATNER |
| 206 |
[GO] |
2021―Jun―24 |
920-P: Understanding CGM Metrics in Children with T1D Before and After the COVID-19 Shelter-in-Place Order |
LAYA EKHLASPOUR, JACQUELINE J. VALLON, JESSICA NGO, PRIYA PRAHALAD, DAVID SCHEINKER, DAVID M. MAAHS |
| 207 |
[GO] |
2021―Jun―24 |
631-P: Reliability of the Freestyle Libre Continuous Monitoring System in the Inpatient Setting: Implications for the COVID-19 Surge |
RENEE MURRAY-BACHMANN, KARINA ZISKOVICH, MULUGETA SARBANES, TUNG MING LEUNG, ALYSON MYERS, SWETHA MURTHI, LEONID PORETSKY |
| 208 |
[GO] |
2021―Jun―24 |
1068-P: Diabetes and Comorbidities Risk Assessment in Hospitalization and Fatalities from the Mexican COVID-19 Surveillance System |
HECTOR GALLARDO-RINCÓN, ALEJANDRA MONTOYA, LUIS ALBERTO MARTINEZ-JUAREZ, JULIETA LOMELIN-GASCON, EDUARDO R. SAUCEDO-MARTINEZ, RICARDO MUJICA-ROSALES, ROBERTO TAPIA-CONYER |
| 209 |
[GO] |
2021―Jun―24 |
515-P: The Impact of COVID-19 Worries on Diabetes Distress and Depressive Symptoms in Older Adults with Type 2 Diabetes |
MIN JUNG KIM, CHANG G. PARK, CYNTHIA FRITSCHI |
| 210 |
[GO] |
2021―Jun―24 |
26-LB: Glycemic Control in People with Type 1 Diabetes Mellitus after the First Portuguese COVID-19-Related State of Emergency |
DIOGO RAMALHO, SARA CORREIA, LÚCIA ALMEIDA, HELENA ALVES, GUSTAVO ROCHA, MARTA FERREIRA, MARIA J. OLIVEIRA |
| 211 |
[GO] |
2021―Jun―24 |
527-P: Pediatric Parenting Stress, Child Behavior, and COVID-19-Specific Parent Functioning among Parents of Youth with Type 1 Diabetes (T1D) |
KELLYANN ROONEY, CHRISTINE H. WANG, MARISA E. HILLIARD, RANDI STREISAND, CHRISTINA DANKO |
| 212 |
[GO] |
2021―Jun―24 |
106-LB: Real-Life Efficacy and Safety of IDegLira in Type 2 Diabetic Patients during COVID-19: A 6-Month Follow-Up by Teleconsultation in Bucaramanga, Colombia |
GUSTAVO A. PARRA SERRANO, MARIA PAULA TORRESLANGHAMMER, SERGIO SERRANOGOMEZ, ANDREA J. PINTOARIAS |
| 213 |
[GO] |
2021―Jun―24 |
61-LB: Continuous Glucose Monitoring (CGM) in ICU Patients during COVID-19: A Pilot Study |
RENU JOSHI, VANESSA M. SNELL, KAREN L. GOOD, YIJIN WERT, AMY M. HELMUTH |
| 214 |
[GO] |
2021―Jun―24 |
222-OR: High Glucose Level Increases Expression of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Receptors |
SESHAGIRI RAO NANDULA, RAJESH NAIDU JANAPALA, SABYASACHI SEN |
| 215 |
[GO] |
2021―Jun―24 |
913-P: Good Concordance between Home Kit A1C, Glucose Management Indicator, and Point-of-Care A1C: Potential Solutions to Glycemic Assessment during the SARS CoV-2 Pandemic |
DESSI ZAHARIEVA, ANANTA ADDALA, PRIYA PRAHALAD, BRIANNA LEVERENZ, VICTORIA DING, MANISHA DESAI, AMY B. KARGER, DAVID M. MAAHS |
| 216 |
[GO] |
2021―Jun―24 |
844-P: Impact of Hypoglycemic Awareness on Diabetes Care during the SARS CoV Pandemic |
CHARLES WATT, MARI-LYNET KNIGHT, ELIZABETH SANCHEZ RANGEL, FELONA GUNAWAN, JANICE J. HWANG |
| 217 |
[GO] |
2021―Jun―24 |
840-P: Evaluation of the Use of Telehealth vs. In-Person Visits on Clinical Process in Aging Patients with Type 1 Diabetes over the Pandemic |
ATIF ADAM, ELENA TOSCHI, MEDHA MUNSHI, LORI M. LAFFEL |
| 218 |
[GO] |
2021―Jun―24 |
855-P: Health Care Delivery for Young Adults (YAs) with Type 1 Diabetes (T1D) during the Pandemic |
AMIT SHAPIRA, LIANE J. TINSLEY, EMILY FREINER, LORI M. LAFFEL, ELENA TOSCHI |
| 219 |
[GO] |
2021―Jun―24 |
167-LB: Pandemic Changes and Usage of At-Home Collected Hemoglobin A1c and Lipid Profiles |
EMMA J. DION, DEVON HUMPHREYS, KAYLAN OLDS, THUSHANI SIRIWARDHANE, TIMOTHY BAUER |
| 220 |
[GO] |
2021―Jun―24 |
566-P: Is a Zoom, Family-Based Intervention Feasible during a Pandemic? |
JESSIE J. WONG, MONICA S. LANNING, JESSICA NGO, CHRISTINE A. WU, SARAH HANES, HALEY M. LINZMEYER, DIANA NARANJO, KOREY K. HOOD |
| 221 |
[GO] |
2021―Jun―24 |
580-P: Sleepless in the Pandemic? Changes in Sleep among Parents with Children with Type 1 Diabetes (T1D) |
SAMANTHA A. CARREON, IMAN AL-GADI, KELLYANN ROONEY, CHRISTINE H. WANG, CARRIE TULLY, JASMINE N. JONES, KATHERINE A. GALLAGHER, MAUREEN MONAGHAN, RANDI STREISAND, MARISA E. HILLIARD |
| 222 |
[GO] |
2021―Jun―15 |
LTB4-driven inflammation and increased expression of ALOX5/ACE2 during severe COVID-19 in individuals with diabetes. |
Icaro Bonyek-Silva, Antônio Fernando Araújo Machado, Thiago Cerqueira-Silva, Sara Nunes, Márcio Rivison Silva Cruz, Jéssica Silva, Reinan Lima Santos, Aldina Barral, Pablo Rafael Silveira Oliveira, Ricardo Khouri, Henrique C. Serezani, Cláudia Brodskyn, Juliana Ribeiro Caldas, Manoel Barral-Netto, Viviane Boaventura, Natalia Machado Tavares |
| 223 |
[GO] |
2021―Feb―25 |
How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic? |
Michael J. Haller, Laura M. Jacobsen, Amanda L. Posgai, Desmond A. Schatz |
| 224 |
[GO] |
2021―Feb―17 |
Obesity and COVID-19 in Adult Patients With Diabetes |
Peihua Cao, Ying Song, Zian Zhuang, Jinjun Ran, Lin Xu, Yan Geng, Lefei Han, Shi Zhao, Jing Qin, Daihai He, Fengfu Wu, Lin Yang |
| 225 |
[GO] |
2020―Dec―11 |
Lung and Kidney ACE2 and TMPRSS2 in Renin Angiotensin System Blocker Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19 |
Sri Nagarjun Batchu, Harmandeep Kaur, Veera Ganesh Yerra, Suzanne L. Advani, MD Golam Kabir, Youan Liu, Thomas Klein, Andrew Advani |
| 226 |
[GO] |
2020―Oct―06 |
Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes |
Sara RA Wijnant, Merel Jacobs, Hannelore P Van Eeckhoutte, Bruno Lapauw, Guy F Joos, Ken R Bracke, Guy G Brusselle |
| 227 |
[GO] |
2020―Sep―16 |
COVID-19 and Diabetes: A Collision and Collusion of Two Diseases |
Eva L. Feldman, Masha G. Savelieff, Salim S. Hayek, Subramaniam Pennathur, Matthias Kretzler, Rodica Pop-Busui |
| 228 |
[GO] |
2020―Aug―10 |
Managing Hyperglycemia in the COVID-19 Inflammatory Storm |
Roma Gianchandani, Nazanene H. Esfandiari, Lynn Ang, Jennifer Iyengar, Sharon Knotts, Palak Choksi, Rodica Pop-Busui |
| 229 |
[GO] |
2020―Jul―15 |
Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19 |
Franck Mauvais-Jarvis |
| 230 |
[GO] |
2020―Jul―15 |
SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes |
Alexander G. Obukhov, Bruce R. Stevens, Ram Prasad, Sergio Li Calzi, Michael E. Boulton, Mohan K. Raizada, Gavin Y. Oudit, Maria B. Grant |
